XM3CD8

ICD-11 MMS 2026-01

Daclizumab

Index terms

  • Daclizumab

Sibling codes

Foundation entity

Daclizumab – http://id.who.int/icd/entity/1546073298

Part of: XM5ZL1: Interleukin inhibitors › XM6WT8: Agents primarily affecting blood constituents or immune system › XM6S30: Medicaments › X: Extension Codes